T1	Condition 18 35	contraindications
T2	Condition 39 55	hypersensitivity
T3	Procedure 67 87	antiplatelet therapy
*	OR T1 T2
T4	Scope 18 55	contraindications or hypersensitivity
R1	AND Arg1:T4 Arg2:T3	
T5	Condition 103 130	Acute Myocardial Infarction
T6	Condition 132 166	ST elevation myocardial infarction
T7	Condition 168 206	Non ST elevation myocardial infarction
*	OR T6 T7
T8	Scope 132 206	ST elevation myocardial infarction, Non ST elevation myocardial infarction
R2	Subsumes Arg1:T5 Arg2:T8	
T9	Mood 226 240	anticipated to
T10	Procedure 249 258	treatment
T11	Procedure 262 269	surgery
T12	Procedure 319 339	antiplatelet therapy
T13	Temporal 340 361	for 2 weeks or longer
*	OR T10 T11
T14	Scope 249 269	treatment or surgery
R3	Has_mood Arg1:T14 Arg2:T9	
R4	AND Arg1:T14 Arg2:T12	
R5	Has_temporal Arg1:T12 Arg2:T13	
T15	Condition 403 426	Chronic total occlusion
T16	Condition 428 431	CTO
T17	Condition 442 461	in-stent restenosis
T18	Condition 463 466	ISR
R6	Subsumes Arg1:T15 Arg2:T16	
R7	Subsumes Arg1:T17 Arg2:T18	
*	OR T15 T17
T19	Condition 491 508	cardiogenic shock
T20	Pregnancy_considerations 510 570	Women who are breastfeeding, pregnant, or desiring pregnancy
T21	Condition 598 608	hemorrhage
T22	Observation 626 641	life expectancy
T23	Value 645 661	less than 1 year
R8	Has_value Arg1:T22 Arg2:T23	
T24	Procedure 692 710;717 726	drug-eluting stent procedure
T25	Procedure 712 715	DES
R9	Subsumes Arg1:T24 Arg2:T25	
T26	Temporal 738 751	past 6 months
R10	Has_temporal Arg1:T24 Arg2:T26	
T27	Non-query-able 753 829	Any other patients judged by the investigator to be unsuitable for the trial
